Brief: Standard BioTools Q2 EPS USD -0.07
05/08/2026 21:06
BRIEF-Standard BioTools Q2 EPS USD -0.07 Aug 05 (Reuters) - Standard BioTools Q2 revenue USD 20.1 million.
- Q2 operating income USD -25.4 million
- Q2 adjusted EBITDA USD -2.5 million
- Q2 pretax profit USD -21.435 million
- Q2 gross margin 52.4%
- Q2 adjusted gross margin 56.3%
- Q2 net income USD -26.758 million
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07